Clinical Hemostatic Material - Global and China Top Players Market Share and Ranking 2023
According to latest Research, the global market for Clinical Hemostatic Material should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Clinical Hemostatic Material market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Clinical Hemostatic Material market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Hemostatic materials can be used to stop bleeding, and the process is realized following various ways. For example, gauze, a traditional hemostatic material, can be used to stop bleeding under conditions of physical compression (realized using pressure wraps). Hemostatic sponges function as efficient absorbents.
This report studies and analyses global Clinical Hemostatic Material status and future trends, helps the client to determine the Clinical Hemostatic Material market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Clinical Hemostatic Material, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Clinical Hemostatic Material market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Clinical Hemostatic Material sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Clinical Hemostatic Material sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Clinical Hemostatic Material key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Clinical Hemostatic Material key producing regions, capacity, production, and year over year growth
(6) Clinical Hemostatic Material industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
Market segment by Type, covers
Natural Biological Material
Synthetic
Market segment by Application, can be divided into
Hospital
Clinic
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Clinical Hemostatic Material product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Clinical Hemostatic Material market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Clinical Hemostatic Material market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Clinical Hemostatic Material, percent & CAGR, 2018-2029
Chapter 5: Clinical Hemostatic Material industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Clinical Hemostatic Material Definition
1.2 Global Clinical Hemostatic Material Market Size and Forecast
1.2.1 By Consumption Value, Global Clinical Hemostatic Material Market Size，2018-2029
1.2.2 By Sales Quantity, Global Clinical Hemostatic Material Market Size，2018-2029
1.2.3 Global Clinical Hemostatic Material Average Selling Price (ASP)，2018-2029
1.3 China Clinical Hemostatic Material Market Size and Forecast
1.3.1 By Consumption Value, China Clinical Hemostatic Material Market Size，2018-2029
1.3.2 By Sales Quantity, China Clinical Hemostatic Material Market Size，2018-2029
1.3.3 China Clinical Hemostatic Material Average Selling Price (ASP)， 2018-2029
1.4 Share of China Clinical Hemostatic Material Market with Respect to the Global Market
1.4.1 By Consumption Value, China Clinical Hemostatic Material Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Clinical Hemostatic Material Market Share in Global, 2018-2029
1.4.3 Clinical Hemostatic Material Market Size: China VS Global, 2018-2029
1.5 Clinical Hemostatic Material Market Dynamics
1.5.1 Clinical Hemostatic Material Market Drivers
1.5.2 Clinical Hemostatic Material Market Restraints
1.5.3 Clinical Hemostatic Material Industry Trends
1.5.4 Clinical Hemostatic Material Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Clinical Hemostatic Material, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Clinical Hemostatic Material, Global Market Share by Company, 2018-2023
2.3 Clinical Hemostatic Material Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Clinical Hemostatic Material Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Clinical Hemostatic Material Concentration Ratio
2.6 Global Clinical Hemostatic Material Mergers & Acquisitions, Expansion Plans
2.7 Global Clinical Hemostatic Material Manufacturers Product Type
2.8 Head Office and Clinical Hemostatic Material Production Site of Key Manufacturer
2.9 Clinical Hemostatic Material Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Clinical Hemostatic Material, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Clinical Hemostatic Material, China Market Share by Company, 2018-2023
3.3 China Clinical Hemostatic Material Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Clinical Hemostatic Material Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Clinical Hemostatic Material Capacity by Region
4.3 Global Clinical Hemostatic Material Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Clinical Hemostatic Material Production by Region, 2018-2029
4.5 Global Clinical Hemostatic Material Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Clinical Hemostatic Material Industry Chain
5.2 Clinical Hemostatic Material Upstream Analysis
5.2.1 Clinical Hemostatic Material Core Raw Materials
5.2.2 Main Manufacturers of Clinical Hemostatic Material Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Clinical Hemostatic Material Production Mode
5.6 Clinical Hemostatic Material Procurement Model
5.7 Clinical Hemostatic Material Industry Sales Model and Sales Channels
5.7.1 Clinical Hemostatic Material Sales Model
5.7.2 Clinical Hemostatic Material Typical Distributors
6 Sights by Type
6.1 Clinical Hemostatic Material Classification
6.1.1 Natural Biological Material
6.1.2 Synthetic
6.2 By Type, Global Clinical Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Clinical Hemostatic Material Consumption Value, 2018-2029
6.4 By Type, Global Clinical Hemostatic Material Sales Quantity, 2018-2029
6.5 By Type, Global Clinical Hemostatic Material Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Clinical Hemostatic Material Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Other
7.2 By Application, Global Clinical Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Clinical Hemostatic Material Consumption Value, 2018-2029
7.4 By Application, Global Clinical Hemostatic Material Sales Quantity, 2018-2029
7.5 By Application, Global Clinical Hemostatic Material Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Clinical Hemostatic Material Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Clinical Hemostatic Material Consumption Value, 2018-2029
8.3 By Region, Global Clinical Hemostatic Material Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Clinical Hemostatic Material & Forecasts, 2018-2029
8.4.2 By Country, North America Clinical Hemostatic Material Market Size Market Share
8.5 Europe
8.5.1 Europe Clinical Hemostatic Material Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Clinical Hemostatic Material Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Clinical Hemostatic Material Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Clinical Hemostatic Material Market Size Market Share
8.7 South America
8.7.1 South America Clinical Hemostatic Material Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Clinical Hemostatic Material Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Clinical Hemostatic Material Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Clinical Hemostatic Material Consumption Value, 2018-2029
9.3 By Country, Global Clinical Hemostatic Material Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Clinical Hemostatic Material Market Size, 2018-2029
9.4.2 By Type, U.S. Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Clinical Hemostatic Material Market Size, 2018-2029
9.5.2 By Type, Europe Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Clinical Hemostatic Material Market Size, 2018-2029
9.6.2 By Type, China Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Clinical Hemostatic Material Market Size, 2018-2029
9.7.2 By Type, Japan Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Clinical Hemostatic Material Market Size, 2018-2029
9.8.2 By Type, South Korea Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Clinical Hemostatic Material Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Clinical Hemostatic Material Market Size, 2018-2029
9.10.2 By Type, India Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Clinical Hemostatic Material Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Clinical Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.1.2 Johnson & Johnson Clinical Hemostatic Material Models, Specifications, and Application
10.1.3 Johnson & Johnson Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Johnson & Johnson Company Profile and Main Business
10.1.5 Johnson & Johnson Recent Developments
10.2 BD
10.2.1 BD Company Information, Head Office, Market Area, and Industry Position
10.2.2 BD Clinical Hemostatic Material Models, Specifications, and Application
10.2.3 BD Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 BD Company Profile and Main Business
10.2.5 BD Recent Developments
10.3 Baxter
10.3.1 Baxter Company Information, Head Office, Market Area, and Industry Position
10.3.2 Baxter Clinical Hemostatic Material Models, Specifications, and Application
10.3.3 Baxter Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Baxter Company Profile and Main Business
10.3.5 Baxter Recent Developments
10.4 B.Braun
10.4.1 B.Braun Company Information, Head Office, Market Area, and Industry Position
10.4.2 B.Braun Clinical Hemostatic Material Models, Specifications, and Application
10.4.3 B.Braun Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 B.Braun Company Profile and Main Business
10.4.5 B.Braun Recent Developments
10.5 Cura Medical
10.5.1 Cura Medical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Cura Medical Clinical Hemostatic Material Models, Specifications, and Application
10.5.3 Cura Medical Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Cura Medical Company Profile and Main Business
10.5.5 Cura Medical Recent Developments
10.6 GELITA MEDICAL
10.6.1 GELITA MEDICAL Company Information, Head Office, Market Area, and Industry Position
10.6.2 GELITA MEDICAL Clinical Hemostatic Material Models, Specifications, and Application
10.6.3 GELITA MEDICAL Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 GELITA MEDICAL Company Profile and Main Business
10.6.5 GELITA MEDICAL Recent Developments
10.7 Curasan AG
10.7.1 Curasan AG Company Information, Head Office, Market Area, and Industry Position
10.7.2 Curasan AG Clinical Hemostatic Material Models, Specifications, and Application
10.7.3 Curasan AG Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Curasan AG Company Profile and Main Business
10.7.5 Curasan AG Recent Developments
10.8 Meril Life Sciences
10.8.1 Meril Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.8.2 Meril Life Sciences Clinical Hemostatic Material Models, Specifications, and Application
10.8.3 Meril Life Sciences Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Meril Life Sciences Company Profile and Main Business
10.8.5 Meril Life Sciences Recent Developments
10.9 Zhonghui Shengxi
10.9.1 Zhonghui Shengxi Company Information, Head Office, Market Area, and Industry Position
10.9.2 Zhonghui Shengxi Clinical Hemostatic Material Models, Specifications, and Application
10.9.3 Zhonghui Shengxi Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Zhonghui Shengxi Company Profile and Main Business
10.9.5 Zhonghui Shengxi Recent Developments
10.10 Beijing Datsing Bio-tech
10.10.1 Beijing Datsing Bio-tech Company Information, Head Office, Market Area, and Industry Position
10.10.2 Beijing Datsing Bio-tech Clinical Hemostatic Material Models, Specifications, and Application
10.10.3 Beijing Datsing Bio-tech Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Beijing Datsing Bio-tech Company Profile and Main Business
10.10.5 Beijing Datsing Bio-tech Recent Developments
10.11 Guizhou Jin Jiu Biotech
10.11.1 Guizhou Jin Jiu Biotech Company Information, Head Office, Market Area, and Industry Position
10.11.2 Guizhou Jin Jiu Biotech Clinical Hemostatic Material Models, Specifications, and Application
10.11.3 Guizhou Jin Jiu Biotech Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Guizhou Jin Jiu Biotech Company Profile and Main Business
10.11.5 Guizhou Jin Jiu Biotech Recent Developments
10.12 Beijing Taikesiman
10.12.1 Beijing Taikesiman Company Information, Head Office, Market Area, and Industry Position
10.12.2 Beijing Taikesiman Clinical Hemostatic Material Models, Specifications, and Application
10.12.3 Beijing Taikesiman Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Beijing Taikesiman Company Profile and Main Business
10.12.5 Beijing Taikesiman Recent Developments
10.13 Foryou Medical
10.13.1 Foryou Medical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Foryou Medical Clinical Hemostatic Material Models, Specifications, and Application
10.13.3 Foryou Medical Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Foryou Medical Company Profile and Main Business
10.13.5 Foryou Medical Recent Developments
10.14 Saikesaisi Holdings Group
10.14.1 Saikesaisi Holdings Group Company Information, Head Office, Market Area, and Industry Position
10.14.2 Saikesaisi Holdings Group Clinical Hemostatic Material Models, Specifications, and Application
10.14.3 Saikesaisi Holdings Group Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Saikesaisi Holdings Group Company Profile and Main Business
10.14.5 Saikesaisi Holdings Group Recent Developments
10.15 Biotemed
10.15.1 Biotemed Company Information, Head Office, Market Area, and Industry Position
10.15.2 Biotemed Clinical Hemostatic Material Models, Specifications, and Application
10.15.3 Biotemed Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Biotemed Company Profile and Main Business
10.15.5 Biotemed Recent Developments
10.16 Hangzhou Singclean Medical Products
10.16.1 Hangzhou Singclean Medical Products Company Information, Head Office, Market Area, and Industry Position
10.16.2 Hangzhou Singclean Medical Products Clinical Hemostatic Material Models, Specifications, and Application
10.16.3 Hangzhou Singclean Medical Products Clinical Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Hangzhou Singclean Medical Products Company Profile and Main Business
10.16.5 Hangzhou Singclean Medical Products Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Clinical Hemostatic Material Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Clinical Hemostatic Material Market Restraints
Table 3. Clinical Hemostatic Material Market Trends
Table 4. Clinical Hemostatic Material Industry Policy
Table 5. Global Clinical Hemostatic Material Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Clinical Hemostatic Material Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Clinical Hemostatic Material Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 8. Global Clinical Hemostatic Material Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Clinical Hemostatic Material Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)
Table 10. Global Clinical Hemostatic Material Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Clinical Hemostatic Material Mergers & Acquisitions, Expansion Plans
Table 12. Global Clinical Hemostatic Material Manufacturers Product Type
Table 13. Head Office and Clinical Hemostatic Material Production Site of Key Manufacturer
Table 14. Clinical Hemostatic Material Capacity of Major Manufacturers and Future Plan
Table 15. China Clinical Hemostatic Material Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Clinical Hemostatic Material Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 17. China Clinical Hemostatic Material Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Clinical Hemostatic Material Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 19. Global Clinical Hemostatic Material Production by Region, 2018-2023, (Tons)
Table 20. Global Clinical Hemostatic Material Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of Clinical Hemostatic Material Upstream (Raw Materials)
Table 22. Global Clinical Hemostatic Material Typical Customers
Table 23. Clinical Hemostatic Material Typical Distributors
Table 24. By Type, Global Clinical Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Clinical Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Clinical Hemostatic Material Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Clinical Hemostatic Material Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Clinical Hemostatic Material Sales Quantity, 2018-2029, (Tons)
Table 29. By Country, Global Clinical Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Clinical Hemostatic Material Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Clinical Hemostatic Material Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Clinical Hemostatic Material Sales Quantity, 2018-2029, (Tons)
Table 33. By Country, Global Clinical Hemostatic Material Sales Quantity Market Share, 2018-2029
Table 34. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 35. Johnson & Johnson Clinical Hemostatic Material Models, Specifications, and Application
Table 36. Johnson & Johnson Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 37. Johnson & Johnson Company Profile and Main Business
Table 38. Johnson & Johnson Recent Developments
Table 39. BD Company Information, Head Office, Market Area, and Industry Position
Table 40. BD Clinical Hemostatic Material Models, Specifications, and Application
Table 41. BD Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. BD Company Profile and Main Business
Table 43. BD Recent Developments
Table 44. Baxter Company Information, Head Office, Market Area, and Industry Position
Table 45. Baxter Clinical Hemostatic Material Models, Specifications, and Application
Table 46. Baxter Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Baxter Company Profile and Main Business
Table 48. Baxter Recent Developments
Table 49. B.Braun Company Information, Head Office, Market Area, and Industry Position
Table 50. B.Braun Clinical Hemostatic Material Models, Specifications, and Application
Table 51. B.Braun Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. B.Braun Company Profile and Main Business
Table 53. B.Braun Recent Developments
Table 54. Cura Medical Company Information, Head Office, Market Area, and Industry Position
Table 55. Cura Medical Clinical Hemostatic Material Models, Specifications, and Application
Table 56. Cura Medical Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Cura Medical Company Profile and Main Business
Table 58. Cura Medical Recent Developments
Table 59. GELITA MEDICAL Company Information, Head Office, Market Area, and Industry Position
Table 60. GELITA MEDICAL Clinical Hemostatic Material Models, Specifications, and Application
Table 61. GELITA MEDICAL Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. GELITA MEDICAL Company Profile and Main Business
Table 63. GELITA MEDICAL Recent Developments
Table 64. Curasan AG Company Information, Head Office, Market Area, and Industry Position
Table 65. Curasan AG Clinical Hemostatic Material Models, Specifications, and Application
Table 66. Curasan AG Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Curasan AG Company Profile and Main Business
Table 68. Curasan AG Recent Developments
Table 69. Meril Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 70. Meril Life Sciences Clinical Hemostatic Material Models, Specifications, and Application
Table 71. Meril Life Sciences Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. Meril Life Sciences Company Profile and Main Business
Table 73. Meril Life Sciences Recent Developments
Table 74. Zhonghui Shengxi Company Information, Head Office, Market Area, and Industry Position
Table 75. Zhonghui Shengxi Clinical Hemostatic Material Models, Specifications, and Application
Table 76. Zhonghui Shengxi Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. Zhonghui Shengxi Company Profile and Main Business
Table 78. Zhonghui Shengxi Recent Developments
Table 79. Beijing Datsing Bio-tech Company Information, Head Office, Market Area, and Industry Position
Table 80. Beijing Datsing Bio-tech Clinical Hemostatic Material Models, Specifications, and Application
Table 81. Beijing Datsing Bio-tech Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Beijing Datsing Bio-tech Company Profile and Main Business
Table 83. Beijing Datsing Bio-tech Recent Developments
Table 84. Guizhou Jin Jiu Biotech Company Information, Head Office, Market Area, and Industry Position
Table 85. Guizhou Jin Jiu Biotech Clinical Hemostatic Material Models, Specifications, and Application
Table 86. Guizhou Jin Jiu Biotech Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 87. Guizhou Jin Jiu Biotech Company Profile and Main Business
Table 88. Guizhou Jin Jiu Biotech Recent Developments
Table 89. Beijing Taikesiman Company Information, Head Office, Market Area, and Industry Position
Table 90. Beijing Taikesiman Clinical Hemostatic Material Models, Specifications, and Application
Table 91. Beijing Taikesiman Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 92. Beijing Taikesiman Company Profile and Main Business
Table 93. Beijing Taikesiman Recent Developments
Table 94. Foryou Medical Company Information, Head Office, Market Area, and Industry Position
Table 95. Foryou Medical Clinical Hemostatic Material Models, Specifications, and Application
Table 96. Foryou Medical Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 97. Foryou Medical Company Profile and Main Business
Table 98. Foryou Medical Recent Developments
Table 99. Saikesaisi Holdings Group Company Information, Head Office, Market Area, and Industry Position
Table 100. Saikesaisi Holdings Group Clinical Hemostatic Material Models, Specifications, and Application
Table 101. Saikesaisi Holdings Group Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 102. Saikesaisi Holdings Group Company Profile and Main Business
Table 103. Saikesaisi Holdings Group Recent Developments
Table 104. Biotemed Company Information, Head Office, Market Area, and Industry Position
Table 105. Biotemed Clinical Hemostatic Material Models, Specifications, and Application
Table 106. Biotemed Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 107. Biotemed Company Profile and Main Business
Table 108. Biotemed Recent Developments
Table 109. Hangzhou Singclean Medical Products Company Information, Head Office, Market Area, and Industry Position
Table 110. Hangzhou Singclean Medical Products Clinical Hemostatic Material Models, Specifications, and Application
Table 111. Hangzhou Singclean Medical Products Clinical Hemostatic Material Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 112. Hangzhou Singclean Medical Products Company Profile and Main Business
Table 113. Hangzhou Singclean Medical Products Recent Developments
List of Figures
Figure 1. Clinical Hemostatic Material Picture
Figure 2. Global Clinical Hemostatic Material Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Clinical Hemostatic Material Sales Quantity, (Tons) & (2018-2029)
Figure 4. Global Clinical Hemostatic Material Average Selling Price (ASP), (2018-2029) & (US$/Ton)
Figure 5. China Clinical Hemostatic Material Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Clinical Hemostatic Material Sales Quantity (Tons) & (2018-2029)
Figure 7. China Clinical Hemostatic Material Average Selling Price (ASP), (US$/Ton) & (2018-2029)
Figure 8. By Consumption Value, China Clinical Hemostatic Material Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Clinical Hemostatic Material Market Share of Global, 2018-2029
Figure 10. Global Clinical Hemostatic Material Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Clinical Hemostatic Material Key Participants, Market Share, 2022
Figure 12. Global Clinical Hemostatic Material Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Clinical Hemostatic Material Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Clinical Hemostatic Material Production Market Share & Forecast by Region, 2018-2029
Figure 15. Clinical Hemostatic Material Industry Chain
Figure 16. Clinical Hemostatic Material Procurement Model
Figure 17. Clinical Hemostatic Material Sales Model
Figure 18. Clinical Hemostatic Material Sales Channels, Direct Sales, and Distribution
Figure 19. Natural Biological Material
Figure 20. Synthetic
Figure 21. By Type, Global Clinical Hemostatic Material Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Clinical Hemostatic Material Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Clinical Hemostatic Material Sales Quantity, 2018-2029, (Tons)
Figure 24. By Type, Global Clinical Hemostatic Material Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Clinical Hemostatic Material Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 26. Hospital
Figure 27. Clinic
Figure 28. Other
Figure 29. By Application, Global Clinical Hemostatic Material Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Clinical Hemostatic Material Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Clinical Hemostatic Material Sales Quantity, 2018-2029, (Tons)
Figure 32. By Application, Global Clinical Hemostatic Material Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Clinical Hemostatic Material Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 34. By Region, Global Clinical Hemostatic Material Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Clinical Hemostatic Material Sales Quantity Market Share, 2018-2029
Figure 36. North America Clinical Hemostatic Material Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, No
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|